LM Funding America trades as part of the credit services industry and is in the financial services sector. The company CEO is Bruce M. Rodgers. LM Funding America Inc is a finance company that provides funding to nonprofit community associations located in the state of Florida and to a lesser extent in the states of Washington and Colorado.

Previous Intraday Performance:

The LMFA shares had a previous change of -9.35% which opened at 1.40 and closed at 1.26. It moved to an intraday high of 1.40 and a low of 1.25.

SeekingAlpha:  LM Funding America reports Q1 results

Historical Performance:

Over the last five trading days, LMFA shares returned -0.79% and in the past 30 trading days it returned -13.10%. Over three months, it changed -14.52%. In one year it has changed -77.42% and within that year its 52 week high was 8.69 and its 52 week low was 1.00. LMFA stock is 26.00% above its 52 week low.

Our calculations result in a 200 day moving average of 2.25 and a 50 day moving average of 1.34. Right now, LMFA stock is trading -43.91% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

SeekingAlpha:  LM Funding America reports Q1 results


The company has a market cap of $3.9m with 3.1m shares outstanding and a float of 3.1m shares. Trading volume was 39,547 shares and has experienced an average volume of 67,122 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for LM Funding America was -0.5 which ended on 31st of December 2018.

Below was the last reported quarterly diluted earnings per share:

1stQtr 2019Reported 05-16-2019: -0.15
4thQtr 2018Reported 04-16-2019: -0.11
3rdQtr 2018Reported 11-14-2018: -0.94
2ndQtr 2018Reported 08-14-2018: 0.70
1stQtr 2018Reported 05-14-2018: -0.01

EPS growth is an important number as it indicates the future prospects of LM Funding America; the EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been -74.40% over the last twelve months.

Indicators Also to Watch:

Based on the latest filings, there is 8.20% of institutional ownership.

The beta was calculated to be 2.36.

PR Newswire:  HRTX Class Action Alert: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Heron Therapeutics, Inc. — HRTX

Fundamental Numbers:

Based on last reported financials, the company’s return on assets is -15.62%, profit margin is -39.09%, price-to-sales is 1.82 and price-to-book is 0.80.

Company Score Card:

Results are out of six:
 0  : Growth Expectations Result
 5  : Financial Safety Result
 0  : Past Performance Result
 1  : Valuation Result
 0  : Dividend Safety Result
 1  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here